Role of molecular diagnostics in the management of viral hepatitis B

Bibliography

• WHO. Hepatitis B. World Health Organization Fact Sheet. 2008
   Google Scholar
• Yang HI, Yeh SH, Chen PJ, Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 2008;100:1134-43
   PubMed Web of Science ®Google Scholar
• Weiser B., Ganem D, Seeger C, Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with ground squirrel hepatitis virus. J Virol 1983;48:1-9
   PubMed Web of Science ®Google Scholar
• Lepere-Douard C, Trotard M, Seyec J, The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity. J Virol 2009;83:11819-29
   PubMed Web of Science ®Google Scholar
• Kao JH. Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroenterol Hepatol 2008;2:553-62
   PubMedGoogle Scholar
• Ganem D, Schneider R. Hepadnaviridae: the viruses and their replication. In: Knipe D, Howley P, Griffin D, Lamb R, Martin M, Roizman B, Strauss S, editors. Fields virology. 4th edition. Lippincott Williams & Wilkins; Philadelphia, PA: 2001. p. 2923-69
   Google Scholar
• Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002;83:2059-73
   PubMed Web of Science ®Google Scholar
• Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198:489-503
   PubMed Web of Science ®Google Scholar
• Stuyver L, De Gendt S, Van Geyt C, A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000;81:67-74
   PubMed Web of Science ®Google Scholar
• Olinger CM, Jutavijittum P, Hubschen JM, Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis 2008;14:1777-80
   PubMed Web of Science ®Google Scholar
• Tatematsu K, Tanaka Y, Kurbanov F, A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009;83:10538-47
   PubMed Web of Science ®Google Scholar
• Norder H, Courouce AM, Coursaget P, Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004;47:289-309
   PubMed Web of Science ®Google Scholar
• Melda BH, Moula NM, Barnes IH, A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 2009;90:1622-8
   PubMed Web of Science ®Google Scholar
• Mulyanto Depamede SN, Surayah K, Tsuda F. A nationwide molecular epidemiological study on hepatitis B virus in Indonesia: identification of two novel subgenotypes, B8 and C7. Arch Virol 2009;154:1047-59
   PubMed Web of Science ®Google Scholar
• Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Novel hepatitis B virus subgenotype A6 in African-Belgian patients. J Clin Virol 2010;47:93-6
   PubMed Web of Science ®Google Scholar
• Lusida MI, Nugrahaputra VE, Soetjipto Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 2008;46:2160-6
   PubMed Web of Science ®Google Scholar
• Koziel MJ, Siddiqui S. Hepatitis B virus and hepatitis delta virus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Elsevier; Philadelphia, PA: 2005
   Google Scholar
• Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Mol Diagn Ther 2006;10:77-91
   PubMed Web of Science ®Google Scholar
• Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006;43:S173-81
   PubMed Web of Science ®Google Scholar
• Chen CJ, Yang HI, Su J, Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73
   PubMed Web of Science ®Google Scholar
• Papatheodoridis GV, Chrysanthos N, Hadziyannis E, Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. J Viral Hepatol 2008;15:434-41
   PubMed Web of Science ®Google Scholar
• Zacharakis G, Koskinas J, Kotsiou S, The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study. J Hepatol 2008;49(6):884-91
   PubMed Web of Science ®Google Scholar
• Funk ML, Rosenberg DM, Lok AS. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat 2002;9:52-61
   PubMed Web of Science ®Google Scholar
• Brechot CV, Thiers D, Kremsdorf B, Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”? Hepatology 2001;34:194-203
   PubMed Web of Science ®Google Scholar
• Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011;17:1927-38
   PubMed Web of Science ®Google Scholar
• Candotti D, Lin CK, Belkhiri D, Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut 2012; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Bhattacharya P, Chandra PK, Datta S, Signifi cant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 2007;13:3730-3
   PubMed Web of Science ®Google Scholar
• Zacharakis GH, Koskinas J, Kotsiou S, Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). J Med Virol 2005;77:173-9
   PubMed Web of Science ®Google Scholar
• Manesis EK, Papatheodoridis GV, Sevastianos V, Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 2003;98:2261-7
   PubMed Web of Science ®Google Scholar
• Wilt TJ, Shamliyan T, Shaukat A, Management of chronic hepatitis B. Evid Rep Technol Assess (Full Rep) 2008;174:1-671
   PubMedGoogle Scholar
• Shamliyan TA, MacDonald R, Shaukat A, Antiviral therapy for adults with chronic hepatitis B: a systematic review for National Institutesof Health Consensus Development Conference. Ann Intern Med 2009;150:111-24
   PubMed Web of Science ®Google Scholar
• Yuen MF, Ng IO, Fan ST, Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients with chronic hepatitis B. Am J Gastroenterol 2004;99:2032-7
   PubMed Web of Science ®Google Scholar
• Chen G, Lin W, Shen F, Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 2006;101:1797-803
   PubMed Web of Science ®Google Scholar
• Chen CJ, Yang HI, Su J, Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73
   PubMed Web of Science ®Google Scholar
• Iloeje U, Yang H, Su J, HBV viral load less than 104 copies/ml is associated with significant risk of hepatocellular carcinoma in chronic hepatitis B patients: an update from the R.E.V.E.A.L. HBV study. Hepatology 2007;46:640A
   PubMedGoogle Scholar
• Wu CF, Yu MW, Lin CL, Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis 2008;29:106-12
   PubMed Web of Science ®Google Scholar
• Fung J, Yuen MF, Yuen JC, Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: a case–control study. Aliment Pharmacol Ther 2007;26:377-82
   PubMed Web of Science ®Google Scholar
• Zacharakis G, Koskinas J, Kotsiou S, The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study. J Hepatol 2008;49:884-91
   PubMed Web of Science ®Google Scholar
• Jang JW, Choi JY, Bae SH, The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence. Cancer 2007;110:1760-7
   PubMed Web of Science ®Google Scholar
• Hung IF, Poon RT, Lai CL, Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am J Gastroenterol 2008;103:1663-73
   PubMed Web of Science ®Google Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B: update. Hepatology 2009;50:661-2
   PubMed Web of Science ®Google Scholar
• Liaw YF, Leung N, Kao JH, Asian–Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008;3:263-83
   Google Scholar
• EASL. Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227-42
   PubMed Web of Science ®Google Scholar
• Yuen MF, Sablon E, Hui CK, Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology 2001;34:785-91
   PubMed Web of Science ®Google Scholar
• Locarnini S, Qi S, Arterburn S, Incidence and predictors of emergence of adefovir resistant HBV during four years of adefovir dipivoxil (ADV) therapy for patients with chronic hepatitis B (CHB). J Hepatol 2005;42:17
   Web of Science ®Google Scholar
• Reijnders JG, Leemans WF, Hansen BE, On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks. J Viral Hepatol 2009;16:113-20
   PubMed Web of Science ®Google Scholar
• Moucari R, Martinot-Peignoux M, Mackiewicz V, Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-a2a. Antivir Ther 2009;14:1183-8
   PubMed Web of Science ®Google Scholar
• Yu MW, Yeh SH, Chen PJ, Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005;97:265-72
   PubMed Web of Science ®Google Scholar
• Kao JH, Chen PJ, Lai MY, Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118:554-9
   PubMed Web of Science ®Google Scholar
• Ni YH, Chang MH, Wang KJ, Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 2004;127:1733-8
   PubMed Web of Science ®Google Scholar
• Erhardt AD, Blondin K, Hauck A, Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut 2005;54:1009-13
   PubMed Web of Science ®Google Scholar
• Datta S, Biswas A, Chandra PK, Molecular epidemiology and clinical significance of hepatitis B virus genotypes, core promoter and pre-core mutations in eastern India. Intervirology 2008;51:275-84
   PubMed Web of Science ®Google Scholar
• Wang Z, Hou J, Zeng G, Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China. J Viral Hepat 2007;14:426-34
   PubMed Web of Science ®Google Scholar
• Chandra PK, Biswas A, Datta S. Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat 2009;16:749-56
   PubMed Web of Science ®Google Scholar
• Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 2011;26(Suppl 1):123-30
   PubMed Web of Science ®Google Scholar
• Wai CT, Chu CJ. Hussain m, et al. HBV genotype B is associated with better response to interferon therapy in HBeAg(_) chronic hepatitis than genotype C. Hepatology 2002;36:1425-30
   PubMed Web of Science ®Google Scholar
• Janssen HL, van Zonneveld M, Senturk H, Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 2005;365:123-9
   PubMed Web of Science ®Google Scholar
• Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance. J Hepatol 2002;36:303-4
   PubMed Web of Science ®Google Scholar
• Benhamou YH, Fleury P, Trimoulet P, Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIVinfected patients. Hepatology 2006;43:548-55
   PubMed Web of Science ®Google Scholar
• Bartholomeusz A, Schaefer S. Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol 2004;14:3-16
   PubMed Web of Science ®Google Scholar
• Banerjee A, Chandra PK, Datta S, Frequency and significance of hepatitis B virus surface gene variant circulating among ‘antiHBc only’ individuals in Eastern India. J Clin Virol 2007;40:312-17
   PubMed Web of Science ®Google Scholar
• Chakravarty R, Neogi M, Roychowdhury S, Presence of hepatitis B surface antigen mutant G145R DNA in the peripheral blood leukocytes of the family members of an asymptomatic carrier and evidence of its horizontal transmission. Virus Res 2002;90:133-41
   PubMed Web of Science ®Google Scholar
• Datta S, Panigrahi R, Biswas A, Genetic characterization of Hepatitis B Virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with immune escape G145R mutation. J Virol 2009;83:9983-92
   PubMed Web of Science ®Google Scholar
• Datta S, Banerjee A, Chandra PK, Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol 2007;40:255-8
   PubMed Web of Science ®Google Scholar
• Biswas A, Banerjee A, Chandra PK, Variations in the functional domain of basal core promoter of Hepatitis B virus among Eastern Indian patients with prevalence of genotypes A, C, and D among the same ethnic population. J Med Virol 2011;83:253-60
   PubMed Web of Science ®Google Scholar
• Datta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J 2008;5:156
   PubMedGoogle Scholar
• Banerjee A, Banerjee S, Chowdhury A, Nucleic acid sequence analysis of basal core promoter/precore/core region of hepatitis B virus isolated from chronic carriers of the virus from Kolkata, eastern India: low frequency of mutation in the precore region. Intervirology 2005;48:389-99
   PubMed Web of Science ®Google Scholar
• Biswas A, Panigrahi R, Banerjee A, Differential pattern of pre-S mutations/deletions and its association with Hepatitis B Virus genotypes in Eastern India. Infect Genet Evol 2012;12:384-91
   PubMed Web of Science ®Google Scholar
• Gao ZY, Li T, Wang J, Mutations in pre-S genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol 2007;42:761-8
   PubMed Web of Science ®Google Scholar
• Yuen MF, Fung J, Wong DK, Lai CL. Prevention and management of drug resistance for antihepatitis B treatment. Lancet Infect Dis 2009;9:256-64
   PubMed Web of Science ®Google Scholar
• Colonno RJ, Rose R, Baldick RJ, Entecavir resistance is rare in nucleoside naive patients with hepatitis B. Hepatology 2006;44:1656-65
   PubMed Web of Science ®Google Scholar
• Yang H, Qi X, Sabogal A, Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV. Antivir Ther 2005;10:625-33
   PubMed Web of Science ®Google Scholar
• Lok AS, Zoulim F, Locarnini S, Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 2007;46:254-65
   PubMed Web of Science ®Google Scholar
• Shaw T, Bartholomeusz A, Locarnini S. HBV drug resistance:mechanisms, detection and interpretation. J Hepatol 2006;44:593-606
   PubMed Web of Science ®Google Scholar
• Yuen LK, Ayres A, Littlejohn M, SEQHEPB: a sequence analysis program and relational database system for chronic hepatitis B. Antiviral Res 2007;75:64-74
   PubMed Web of Science ®Google Scholar
• Allen MI, Deslauriers M, Andrews CW, Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 1998;27:1670-7
   PubMed Web of Science ®Google Scholar
• Angus P, Vaughan R, Xiong S, Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 2003;125:292-7
   PubMed Web of Science ®Google Scholar
• Tenney DJ, Levine SM, Rose RE, Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine. Antimicrob Agents Chemother 2004;48:3498-507
   PubMed Web of Science ®Google Scholar
• Tenney DJ, Rose RE, Baldick CJ, Two-year assessment of entecavir resistance in lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present. Antimicrob Agents Chemother 2007;51:902-11
   PubMed Web of Science ®Google Scholar
• Panigrahi R, Biswas A, Datta S, Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J 2010;7:204
   PubMed Web of Science ®Google Scholar
• Vermeulen M, Dickens C, Lelie N, Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion 2012;2:880-92
   Google Scholar
• Yang MH, Li L, Hung YS, The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion 2010;50:65-74
   PubMed Web of Science ®Google Scholar
• Tomono T, Murokawa H, Minegishi K, Status of NAT screening for HCV, HIV and HBV: experience in Japan. Dev Biol (Basel) 2002;108:29-39
   PubMedGoogle Scholar
• Werle-Lapostolle BS, Bowden A, Locarnini S, Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004;126:1750-8
   PubMed Web of Science ®Google Scholar
• Wong DK, Yuen MF, Poon RT, Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol 2006;45:553-9
   PubMed Web of Science ®Google Scholar
• Yuen MF, Wong DK, Sum SS, Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection. Am J Gastroenterol 2005;100:1099-103
   PubMed Web of Science ®Google Scholar
• Thio CL, Seaberg EC, Skolasky R Jr, HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002;360:1921-6
   PubMed Web of Science ®Google Scholar
• N'Dri-Yoman T, Anglaret X, Messou E, Occult HBV infection in untreated HIV-infected adults in Cote d'Ivoire. Antivir Ther 2010;15:1029-34
   PubMed Web of Science ®Google Scholar
• Margeridon-Thermet S, Shulman NS, Ahmed A, Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis 2009;199:1275-85
   PubMed Web of Science ®Google Scholar
• Gupta S, Singh S. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India. BMC Infect Dis. 2010;10:53
   PubMed Web of Science ®Google Scholar